DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 32 filers reported holding DEPOMED INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,307,000 | +18.7% | 12,635,000 | +18.8% | 1.03% | -10.1% |
| Q3 2019 | $7,844,000 | -79.8% | 10,635,000 | -80.1% | 1.14% | -55.3% |
| Q2 2019 | $38,770,000 | -17.5% | 53,500,000 | -12.3% | 2.56% | +77.4% |
| Q1 2019 | $46,970,000 | +12.9% | 61,000,000 | 0.0% | 1.44% | +17.6% |
| Q4 2018 | $41,615,000 | -9.9% | 61,000,000 | +7.9% | 1.23% | +32.3% |
| Q2 2018 | $46,168,000 | +10.7% | 56,516,000 | +10.8% | 0.93% | +37.8% |
| Q1 2018 | $41,706,000 | -2.7% | 51,016,000 | 0.0% | 0.67% | -11.8% |
| Q4 2017 | $42,853,000 | +42.5% | 51,016,000 | +26.0% | 0.76% | +69.8% |
| Q3 2017 | $30,071,000 | +56.5% | 40,500,000 | +170.0% | 0.45% | +86.0% |
| Q2 2015 | $19,219,000 | -42.4% | 15,000,000 | -40.6% | 0.24% | -47.4% |
| Q1 2015 | $33,377,000 | +76.7% | 25,250,000 | +44.3% | 0.46% | +90.9% |
| Q4 2014 | $18,889,000 | -3.3% | 17,500,000 | -5.4% | 0.24% | -6.6% |
| Q3 2014 | $19,529,000 | – | 18,500,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 4,500,000 | $3,964,000 | 2.82% |
| Telemetry Investments, L.L.C. | 5,000,000 | $4,388,000 | 2.06% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 23,500,000 | $20,904,000 | 1.92% |
| CQS Cayman LP | 17,000,000 | $15,174,000 | 1.04% |
| Sonora Investment Management, LLC | 5,275,000 | $4,639,890,000 | 0.88% |
| LINDEN ADVISORS LP | 19,150,000 | $16,881,000 | 0.71% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 47,500,000 | $41,919,000,000 | 0.69% |
| MACKAY SHIELDS LLC | 14,016,000 | $12,344,000 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 27,933,000 | $24,614,000 | 0.47% |
| Senvest Management, LLC | 5,000,000 | $4,419,000 | 0.35% |